Funding for this research was provided by:
the natural science foundation of Hebei Province (H2013206147, C2018206297, H2013206147, C2018206297)
the Natural Science Foundation of China (NSFC, 81773828)
the key project of Administration of Traditional Chinese medicine of Hebei Province (Z2022013)
Received: 18 June 2021
Accepted: 7 April 2022
First Online: 15 April 2022
: The study was approved by the ethics committee of the Center for New Drug Safety Evaluation and Research, Hebei Medical University (IACUC-Hebyd AP-2016008). All methods were carried out in accordance with relevant guidelines and regulations and in compliance with the ARRIVE guidelines.
: Not applicable.
: The authors declare that they have no conflicts of interest to disclose.